Mostrando ítems 1-12 de 12

    • Consideraciones sobre la infección por HTLV-1 en España 

      de Mendoza, Carmen; Aguilera, Antonio; Eirós, José M.; Soriano, Vicente (Medicina clinica, 2021)
      Consideraciones sobre la infección por HTLV-1 en España.
    • Hepatitis delta in patients hospitalized in Spain (1997-2018) 

      Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; Ramos-Belinchón, Clara; de Mendoza, Carmen; Aguilera, Antonio; Soriano, Vicente (NLM (Medline), 2021)
      BACKGROUND: Hepatitis delta is the most aggressive form of chronic viral hepatitis. We examined the clinical burden, epidemiological features and time trends for hepatitis delta patients hospitalized in Spain during the ...
    • Hepatitis delta in patients with resolved hepatitis B virus infection 

      Aguilera, Antonio; Rodríguez-Calviño, Javier; Mendoza, Carmen de; Soriano, Vicente (European Journal of Gastroenterology & Hepatology, 09/2018)
      Background The hepatitis delta virus (HDV) causes the most aggressive form of chronic viral hepatitis. As HDV replication requires hepatitis B virus (HBV), HDV screening is limited to HBsAg+ carriers. To date, individuals ...
    • HIV co-infection in HTLV-1 carriers in Spain 

      Mendoza, Carmen de; Caballero, Estrella; Aguilera, Antonio; Benito, Rafael; Maciá, Dolores; García-Costa, Juan; Soriano, Vicente ; Corral, Octavio Jorge ; Gómez-Gallego, Felix ; ...et al.; Morano, Luis (Virus Research, 06/2019)
      Background: Human retroviruses HIV and HTLV share transmission routes. HIV widely spread in Spain during the 80 s through injection drug use and sex, and nowadays HIV rates in Spain account for one of the largest in Europe. ...
    • Hospital admissions in individuals with HTLV-1 infection in Spain 

      Ramos, José M.; Mendoza, Carmen de; Aguilera, Antonio; Barreiro, Pablo; Benito, Rafael; Eirós, José M.; Soriano, Vicente (AIDS, 06/2020)
      OBJECTIVE: To examine the clinical burden and disease spectrum, as well as time trends for human T-cell leukemia virus type 1 (HTLV-1) and HTLV type 2 (HTLV-2) hospital admissions. DESIGN: Retrospective, observational study ...
    • Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network 

      de Mendoza, Carmen; Pérez, Leire; Fernández-Ruiz, Mario; Pena, María José; Ramos, José Manuel; Richart, Alberto; Pirón, María; Rando, Ariadna; Miró, Elisenda; Reina, Gabriel; Encinas, Beatriz; Rojo, Silvia; Rodriguez-Iglesias, Antonio Manuel; Benito, Rafael; Aguilera, Antonio; Treviño, Ana; Corral, Octavio Jorge; Soriano, Vicente (International Journal of Infectious Diseases, 2022)
      Objectives: Although only 10% of persons infected with human T-lymphotropic virus type 1 (HTLV-1) may develop virus-associated illnesses over their lifetime, missing the earlier diagnosis of asymptomatic carriers frequently ...
    • Occult hepatitis B and HIV infection 

      Soriano, Vicente ; Aguilera, Antonio; González, Rocío; Gómez-Gallego, Felix ; Barea, Luisa; Treviño, Mercedes; Corral, Octavio Jorge (European Journal of Gastroenterology & Hepatology, 11/2019)
      Introduction Occult hepatitis B virus (HBV) infection, so-called occult B infection (OBI), is defined by the recognition of HBV-DNA in the absence of serum hepatitis B surface antigen (HBsAg). The HBV-DNA genome in OBI is ...
    • Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain 

      Aguilera, Antonio; Trastoy, Rocío; Rodríguez-Calviño, Javier; Manso, Tamara; Mendoza, Carmen de; Soriano, Vicente (European Journal of Gastroenterology & Hepatology, 09/2018)
      Background Hepatitis delta virus (HDV) is a defective agent that only replicates in the presence of the hepatitis B virus. Accordingly, HDV acquisition may occur as superinfection of HBsAg+ carriers or following acute dual ...
    • Should HIV Patients be concerned about Occult Hepatitis B? 

      Aguilera, Antonio; Soriano, Vicente (AIDS Reviews, 10/2018)
      In HIV disease, infection is universally followed by chronification, and therefore, recognition of anti-HIV antibodies always reflects HIV persistence.
    • Susceptibility to hepatitis B virus infection in adults living in Spain 

      Soriano, Vicente; Aguilera, Antonio; Benito, Rafael; Gonzalez-Diez, Rocio; Miro, Elisenda; Liendo, Paloma; Rodriguez-Diaz, Juan Carlos; Cabezas, Teresa; Richart, Alberto; Ramos, José Manuel; Barea, Luisa; Alvarez, Carmen; Treviño, Ana; Gómez-Gallego, Felix; Corral, Octavio Jorge; de Mendoza, Carmen (Liver International, 2023)
      BackgroundA protective hepatitis B virus (HBV) vaccine has been available for four decades. Universal HBV vaccination of infants is recommended by the WHO since the 1990s. Furthermore, HBV immunization is advised for all ...
    • The slowdown of new infections by human retroviruses has reached a plateau in Spain 

      de Mendoza, Carmen; Carrizo, Paula; Sauleda, Silvia; Richart, Alberto; Rando, Ariadna; Miró, Elisenda; Benito, Rafael; Ayerdi, Oscar; Encinas, Begoña; Aguilera, Antonio; Reina, Gabriel; Rojo, Silvia; González, Rocío; Fernández-Ruiz, Mario; Liendo, Paloma; Montiel, Natalia; Roc, Lourdes; Treviño, Ana; Pozuelo, María José; Soriano, Vicente (Journal of Medical Virology, 2023)
      The 2022 annual meeting of the HTLV & HIV-2 Spanish Network was held in Madrid on December 14. We summarize here the main information presented and discussed at the workshop and review time trends for human retroviral ...
    • The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America 

      Trastoy, Rocío; González-Alba, José María; Soriano, Vicente ; Rodríguez-Calviño, José Javier; de Mendoza, Carmen; Costa, José Javier; Cea, María; Barbeito, Gema; Corral, Octavio Jorge ; Gómez-Gallego, Felix ; Pérez del Molino, María Luisa; Carlos Galán, Juan; Aguilera, Antonio (Journal of Clinical Virology, 2022)
      Background: Hepatitis B virus (HBV) comprises 9 genotypes and multiple subgenotypes that depict differences in geographic distribution, clinical outcome and response to antiviral therapy. However, the molecular epidemiology ...